![Thomas Boesen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Boesen
Chief Operating Officer at
SYNACT PHARMA AB
Net worth: 446 250 $ as of 30/05/2026
Profile
Thomas Boesen was the founder of TXP Pharma GmbH.
Current job included Chief Operating Officer at SynAct Pharma AB since 2021.
Former jobs include Director-Drug Discovery at EpiTherapeutics ApS, Principal at Lica Pharmaceuticals A, and Vice President-Discovery at Action Pharma A. Education includes a graduate degree from The University of Edinburgh, graduate and doctorate degrees from the University of Copenhagen, and a graduate degree from Roskilde University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SYNACT PHARMA AB 0.44% | 30/12/2024 | 236,529 ( 0.44% ) | 446 250 $ | 30/05/2026 |
Thomas Boesen active positions
| Companies | Position | Start |
|---|---|---|
| SYNACT PHARMA AB | Chief Operating Officer | 25/01/2021 |
Former positions of Thomas Boesen
| Companies | Position | End |
|---|---|---|
TXP Pharma GmbH | Founder | - |
Lica Pharmaceuticals A/S
 Lica Pharmaceuticals A/S Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research and development services | Corporate Officer/Principal | - |
EpiTherapeutics ApS
 EpiTherapeutics ApS Pharmaceuticals: MajorHealth Technology Develops cancer drugs based on epigenetics | Corporate Officer/Principal | - |
Action Pharma A/S
 Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products | Corporate Officer/Principal | - |
Training of Thomas Boesen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lica Pharmaceuticals A/S
Lica Pharmaceuticals A/S Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research and development services | Commercial Services |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Action Pharma A/S
Action Pharma A/S BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Roskilde University
 Roskilde University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EpiTherapeutics ApS
EpiTherapeutics ApS Pharmaceuticals: MajorHealth Technology Develops cancer drugs based on epigenetics | Health Technology |
SynAct Pharma AB
 SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
TXP Pharma GmbH |
- Stock Market
- Insiders
- Thomas Boesen
